The AJMC® clinical page includes all the published content across AJMC.com, The American Journal of Managed Care® and Evidence-Based Oncology™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.
April 28th 2025
From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ground.
Dr Anne Barmettler Discusses Potential Adverse Events Associated With Teprotumumab
February 7th 2022Anne Barmettler, MD, an associate professor of ophthalmology, visual sciences, and plastic surgery at Montefiore Medical Center, outlines adverse events patients taking teprotumumab for thyroid eye disease may experience.
Watch
Diagnosing Glaucoma: Unmet Needs and Gaps in Education
Panelists discuss the worldwide gaps in diagnosis of glaucoma and how this negatively affects patient outcomes.
Watch
Real-world HIV Diagnostic Testing Patterns in the United States
This retrospective study evaluated real-world implementation of the updated CDC HIV algorithm in a large US laboratory.
Read More
Liquid Biopsy May Have Prognostic, Theranostic Benefits in PDAC
February 5th 2022Despite being the most common pancreatic cancer, pancreatic ductal adenocarcinoma (PDAC) is notoriously difficult to treat, while new research shows treatment and diagnosis could benefit from minimally invasive liquid-based biopsy.
Read More
Patients With EoE Have High Level of HCRU, Analysis Finds
February 5th 2022This retrospective study using administrative claims data examining health care resource utilization (HCRU) found that in the months before a diagnosis of eosinophilic esophagitis (EoE), other diseases were more commonly diagnosed.
Read More
Routine Lung CT Reports Have Diagnostic and Prognostic Utility in Pulmonary Hypertension Subtypes
February 5th 2022Idiopathic pulmonary arterial hypertension and pulmonary hypertension due to chronic lung disease can be difficult to differentiate, but new research suggests descriptions of lung parenchyma in routine CT scans may prove useful.
Read More
Study Assesses Real-world Outcomes of Immunotherapy in Patients With HCC, Comorbidities
February 3rd 2022A poster presentation from the 2022 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium suggests more research is needed to confirm the optimal treatment algorithms for patients with hepatocellular carcinoma.
Read More
Although clinical trials have demonstrated the utility of procalcitonin (PCT) testing and potential benefit on antibiotic stewardship, findings suggest that clinicians do not order PCT testing with regularity and also prioritize clinical judgment over PCT results.
Read More
Meta-Analysis Points to Beneficial Role of Dexamethasone Pretreatment in NSCLC
February 2nd 2022A meta-analysis on first-line treatment for non–small cell lung cancer (NSCLC) in clinical trials revealed that inclusion of dexamethasone along side chemotherapy and PD-L1 inhibitors yielded benefits in this patient population.
Read More
Sinonasal CT Scores May Predict Prognostic Features of Chronic Rhinosinusitis With Nasal Polyps
February 2nd 2022Sinonasal CT scores were associated with several prognostic features in the disease course of chronic rhinosinusitis with nasal polyps, including blood eosinophil counts and risk of relapse after endoscopic sinus surgery.
Read More
Overall Effectiveness of Atrial Shunt for HFpEF Remains Questionable
February 1st 2022There is a persistent lack of effective treatments for heart failure with preserved ejection fraction (HFpEF), so in this study, investigators examined the impact of an atrial shunt among patients with this disease subtype.
Read More
Risdiplam May Be Superior for Certain SMA Type, According to Indirect Comparison
January 30th 2022Researchers compiled data from studies of oral Evrysdi (risdiplam), Spinraza (nusinersen), and Zolgensma (onasemnogene abeparvovec), finding evidence that risdiplam may be a favorable alternative to nusinersen for type 1 SMA.
Read More